Center for Neurological Diseases, Brigham and Women's Hospital, Harvard Medical School — Boston, Massachusetts

Center for Neurological Diseases, Brigham and Women's Hospital, Harvard Medical School is a clinical research site located in Boston, Massachusetts, United States 02115.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Center for Neurological Diseases, Brigham and Women's Hospital, Harvard Medical School has participated in 1 clinical trials.

Therapeutic areas: Multiple Sclerosis (MS) - Relapsing-remitting.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Center for Neurological Diseases, Brigham and Women's Hospital, Harvard Medical School?

Center for Neurological Diseases, Brigham and Women's Hospital, Harvard Medical School has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Center for Neurological Diseases, Brigham and Women's Hospital, Harvard Medical School conducted?

Center for Neurological Diseases, Brigham and Women's Hospital, Harvard Medical School has 1 clinical trials on record. Their work covers Multiple Sclerosis (MS) - Relapsing-remitting.

Is Center for Neurological Diseases, Brigham and Women's Hospital, Harvard Medical School accredited by Crixeo Health?

Center for Neurological Diseases, Brigham and Women's Hospital, Harvard Medical School has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Center for Neurological Diseases, Brigham and Women's Hospital, Harvard Medical School?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.